Skip to content
dimemorfan

Structure via PubChem · Public domain (PubChem)

EntityQ5277240· pop 6· linked from 255 articles

dimemorfan

Sign in to save

Also known as dimemorphan

Dimemorfan (INN; JAN dimemorfan phosphate; also known as dimemorphan and 3,17-dimethylmorphinan; brand names Astomin, Dastosirr, and Tusben) is an antitussive (cough suppressant) of the morphinan family that is widely used in Japan and is also marketed in Spain and Italy. It was developed by Yamanouchi Pharmaceutical (now Astellas Pharma) and introduced in Japan in 1975. It was later introduced in Spain in 1981 and Japan in 1985.

Chemical data

Formula
C18H25N
Molecular weight
255.4 g/mol
IUPAC name
(1S,9S,10S)-4,17-dimethyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene
SMILES
CC1=CC2=C(C[C@H]3[C@@H]4[C@]2(CCCC4)CCN3C)C=C1
InChIKey
KBEZZLAAKIIPFK-NJAFHUGGSA-N
XLogP
3.8
Polar surface area
3.2 Ų
H-bond donors
0
H-bond acceptors
1
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Phase 2
Molecule type
Small molecule
Indications
Cough

via ChEMBL · EBI

Wikidata facts

Mass
255.199
Show 4 more facts
chemical formula
C₁₈H₂₅N
isomeric SMILES
CC1=CC2=C(C[C@H]3[C@@H]4[C@]2(CCCC4)CCN3C)C=C1
canonical SMILES
CC1=CC2=C(CC3C4C2(CCCC4)CCN3C)C=C1
subject has role
antitussive
Sources (2)

via Wikidata · CC0

~1 min read

Encyclopedic overview

4 sections
Contents
  • Side effects
  • Pharmacology
  • See also
  • References

Dimemorfan (INN; JAN dimemorfan phosphate; also known as dimemorphan and 3,17-dimethylmorphinan; brand names Astomin, Dastosirr, and Tusben) is an antitussive (cough suppressant) of the morphinan family that is widely used in Japan and is also marketed in Spain and Italy. It was developed by Yamanouchi Pharmaceutical (now Astellas Pharma) and introduced in Japan in 1975. It was later introduced in Spain in 1981 and Japan in 1985.

==Side effects== Adverse effects include nausea, somnolence, dry mouth, and decreased appetite.

Excerpted from Wikipedia’s “dimemorfan” article, available under the CC BY-SA 4.0 licence.

Available in 6 languages

via Wikidata sitelinks · CC0